Diabetes Risk and Health Policy Proposals Top Healthcare News

A look at the latest news in healthcare, including a study that identifies an increased risk of diabetes in cancer survivors, 2 FDA approvals, Senator Bernie Sanders released a plan for universal healthcare coverage in the US, and the economics of aging.

Related Videos

Related Content

Advertisement

January 10th 2025

Researchers Identify Potential Novel Indicator of Dysphagia in MG

AJMC Contributor

Respiratory patterns and submental surface electromyography may be a reliable indicator of dysphagia among patients with myasthenia gravis.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

January 9th 2025

Subcutaneous Isatuximab Meets Primary End Points in Phase 3 Study for MM

Mary Caffrey

If the subcutaneous delivery method gains approval, an advantage daratumumab holds over isatuximab would be removed.

December 19th 2024

Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma

Giuliana Grossi

Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.

January 9th 2025

Medical Loss Ratio’s Role in the Large Group Insurer Market

Amanda C. Chen, MS David C. Grabowski, PhD Erin Trish, PhD

The authors used medical loss ratio forms to assess trends in premiums, medical claims, administrative costs, quality improvement, and margins in the large group insurer market.

January 9th 2025

Real-World Discontinuations of Ocrelizumab in MS Comparable to Pivotal Trials

AJMC Contributor

Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in pivotal clinical trials among patients with different types of multiple sclerosis (MS).

Related Content

Advertisement

January 10th 2025

Researchers Identify Potential Novel Indicator of Dysphagia in MG

AJMC Contributor

Respiratory patterns and submental surface electromyography may be a reliable indicator of dysphagia among patients with myasthenia gravis.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

January 9th 2025

Subcutaneous Isatuximab Meets Primary End Points in Phase 3 Study for MM

Mary Caffrey

If the subcutaneous delivery method gains approval, an advantage daratumumab holds over isatuximab would be removed.

December 19th 2024

Frameworks for Advancing Health Equity: Pharmacy Support for Non-Hodgkin Lymphoma

Giuliana Grossi

Rachael Drake, pharmacy technician coordinator, University of Kansas Health System, explains how her team collaborates with insurance companies and providers to support treatment access for patients with non-Hodgkin lymphoma.

January 9th 2025

Medical Loss Ratio’s Role in the Large Group Insurer Market

Amanda C. Chen, MS David C. Grabowski, PhD Erin Trish, PhD

The authors used medical loss ratio forms to assess trends in premiums, medical claims, administrative costs, quality improvement, and margins in the large group insurer market.

January 9th 2025

Real-World Discontinuations of Ocrelizumab in MS Comparable to Pivotal Trials

AJMC Contributor

Data from a systematic review of 30 real-world studies show comparable discontinuation rates of ocrelizumab to those in pivotal clinical trials among patients with different types of multiple sclerosis (MS).